Table 2.
Characteristics of patients in the COP group, stratified by management modality (n = 38).
| Surgery sub-group (n = 3) | NACT sub-group (n = 10) | PDT sub-group (n = 25) | |
|---|---|---|---|
| Age (years) | 35 (25-36) | 33 (23-37) | 34 (23-45) |
| GA at diagnosis (weeks) | 18(6-25) | 26 (19-32) | 37 (9-41) |
| FIGO Stage, n (%) | |||
| ≤IB1 | 3 (20) | 2 (13.3) | 10 (66.7) |
| >IB1 | 0 (0) | 8 (34.8) | 15 (65.2) |
| Pathological type, n (%) | |||
| Squamous cell carcinoma | 2 (6.7) | 8 (26.7) | 20 (66.7) |
| Non–squamous cell carcinoma | 1 (12.5) | 2 (25) | 5 (62.5) |
| Tumor size, n (%) | |||
| ≤4 cm | 3 (18.8) | 2 (12.5) | 11 (68.8) |
| <4 cm | 0 (0) | 8 (36.4) | 14 (63.6) |
| GA at delivery (weeks) | 36 (34–38) | 34 (30–35) | 37 (28–41) |
| Delivery weight (grams) | 3,290 (1,700–3,320) | 2,352 (1,350–2,610) | 2,980 (1,315–4,050) |
| Mother's outcome, n (%) | |||
| DOD | 1 (33.3) | 0 (0) | 2 (66.7) |
| NED | 2 (6.5) | 10 (32.3) | 19 (61.3)* |
DOD, dead of disease; NED, no evidence of disease; ND, not determined; GA, gestational age; NACT, neoadjuvant chemotherapy; PDT, post-delivery treatment.
*
Another four cases were lost to follow-up.